Gilenya 0.5 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FY8ZM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $103,162
Award facts
- Contract value 100% obligated
- $103,162.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $103,162.18 to AmerisourceBergen Drug Corp for the supply of Gilenya 0.5 mg capsules (30-count units) on August 7, 2025, with completion scheduled for August 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as the primary pharmaceutical supply vehicle for military and federal healthcare systems.
Gilenya is a specialty neurological medication used in the treatment of multiple sclerosis, reflecting the breadth of therapeutic pharmaceuticals supplied through DLA's pharmaceutical support programs. AmerisourceBergen's role as a prime pharmaceutical vendor enables it to deliver critical medical commodities including brand-name and generic medications, vaccines, and specialized supplies to support Defense Health Agency operations and other federal healthcare systems. The short completion timeline of one day underscores the urgent nature of pharmaceutical procurement requirements within the military medical supply chain and demonstrates the vendor's capability to rapidly fulfill federal medical product demands.
Quick answers
Who was awarded contract SPE2DB25FY8ZM?
SPE2DB25FY8ZM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 7, 2025.
How much is contract SPE2DB25FY8ZM worth?
The government has obligated $103,162 on SPE2DB25FY8ZM.
Is contract SPE2DB25FY8ZM an order under another contract?
Yes. SPE2DB25FY8ZM is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FY8ZM competed?
The extent of competition for SPE2DB25FY8ZM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award